MID-AMER. APARTM. COMM./ US59522J1034 /
6/21/2024 9:55:01 PM | Chg. +0.6000 | Volume | Bid9:59:51 PM | Ask9:59:58 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
131.2000EUR | +0.46% | 0 Turnover: 0.0000 |
-Bid Size: - | -Ask Size: - | 15.4 bill.EUR | - | - |
GlobeNewswire
3:00 AM
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Dir...
GlobeNewswire
2:45 AM
Novotech Liver Cancer Research Landscape Report Finds 1,700 Trials Initiated Globally
GlobeNewswire
1:44 AM
ROSEN, LEADING INVESTOR COUNSEL, Encourages UiPath, Inc. Investors to Secure Counsel Before Importan...
GlobeNewswire
1:35 AM
ROSEN, LEADING INVESTOR COUNSEL, Encourages NIKE, Inc. Investors to Secure Counsel Before Important ...
GlobeNewswire
6/22
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MacroGenics, In...
GlobeNewswire
6/22
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Masimo Corporati...
GlobeNewswire
6/22
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of FutureFuel Corp....
GlobeNewswire
6/22
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bolt Biotherapeu...
GlobeNewswire
6/22
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Regeneron Pharma...
GlobeNewswire
6/22
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Hesai Group - HS...